San Diego-based life sciences company Illumina Inc’s proposed buy of cancer test maker GRAIL Inc faces a lengthy EU antitrust investigation if it does not offer hefty concessions this week, people familiar with the matter said on Tuesday.
San Diego-based life sciences company Illumina Inc’s proposed buy of cancer test maker GRAIL Inc faces a lengthy EU antitrust investigation if it does not offer hefty concessions this week, people familiar with the matter said on Tuesday.